Adimmune Corp.

Adimmune Corp.
Stock Exchange Taiwan Stock Exchange
EPS
TWD2.53
Market Cap
TWD8.37 T
Shares Outstanding
362.35 M
Public Float
-

Profile

Address
No. 3, Sec. 1, Tanxing Road
Taichung TX 427 23
Taiwan
Employees -
Website http://www.adimmune.com.tw
Updated 07/08/2019
Adimmune Corp. engages in the development, manufacture, and distribution of human vaccine. Its products include seasonal influenza vaccine, Japanese encephalitis vaccine, and tetanus toxoid alum precipitated. The company also provides fill and finish services, testing/analysis services, quality assurance courses, and consulting services.

Financials

View All
Created with Highcharts 5.0.14Adimmune Corp.Net Income. Fiscal year is January-December. All values TWD Thousands.600 453600 453614 422614 422761 087761 087595 352595 352760 176760 176609 117609 1172013201420152016201720180200k400k600k800k
Created with Highcharts 5.0.14Adimmune Corp.Sales/Revenue. Fiscal year is January-December. All values TWD Thousands.414 093414 093480 506480 506290 737290 737606 725606 725562 743562 743822 366822 3662013201420152016201720180200k400k600k800k1 000k

Chi Hsien Chan
Chairman
Hsiao Tang Chen
Director